Azenta Life Sciences Reports Results of First Quarter of Fiscal 2022, Ended December 31, 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- US stock futures dip as oil breaches $100 mark for the first time since mid-year
- Oil nears $100 as fresh Middle East strikes raise supply risks
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Azenta, Inc. (AZTA) PT Lowered to $115 at Needham & Company
February 9, 2022 6:59 AM ESTNeedham & Company analyst David Saxon lowered the price target on Azenta, Inc. (NASDAQ: AZTA) to $115.00 (from $155.00) while maintaining a Buy rating.
The analyst commented, "AZTAs F1Q22 revenue and EPS beat consensus and management provided F2Q22 revenue and EPS guidance that... More
Azenta, Inc. (AZTA) Tops Q1 EPS by 4c
February 8, 2022 4:07 PM ESTAzenta, Inc. (NASDAQ: AZTA) reported Q1 EPS of $0.12, $0.04 better than the analyst estimate of $0.08. Revenue for the quarter came in at $140 million versus the consensus estimate of $135.42 million.
GUIDANCE:
Azenta, Inc. sees Q2 2022 EPS of $0.07-$0.15, versus the consensus of... More
